These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21071951)

  • 1. Integration of cognitive impairment in the expanded disability status scale of 215 patients with multiple sclerosis.
    Brissart H; Sauvée M; Latarche C; Dillier C; Debouverie M
    Eur Neurol; 2010; 64(6):345-50. PubMed ID: 21071951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Deloire M; Ruet A; Hamel D; Bonnet M; Brochet B
    Mult Scler; 2010 May; 16(5):581-7. PubMed ID: 20194578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of fatigue in multiple sclerosis.
    Bergamaschi R; Romani A; Versino M; Poli R; Cosi V
    Funct Neurol; 1997; 12(5):247-51. PubMed ID: 9439942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sleepiness and fatigue in multiple sclerosis - comparison of different measuring instruments].
    Kotterba S; Eren E; Fangerau T; Malin JP; Sindern E
    Fortschr Neurol Psychiatr; 2003 Nov; 71(11):590-4. PubMed ID: 14608510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of fatigue in multiple sclerosis: study of a population-based series in Valladolid].
    Tola MA; Yugueros MI; Fernández-Buey N; Fernández-Herranz R
    Rev Neurol; 1998 Jun; 26(154):930-3. PubMed ID: 9658463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of various scales of fatigue and impact on the quality of life among patients with multiple sclerosis].
    Casanova B; Coret F; Landete L
    Rev Neurol; 2000 Jun 16-30; 30(12):1235-41. PubMed ID: 10935257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory impairment in multiple sclerosis and its determinant factors.
    Sedighi B
    Neurosciences (Riyadh); 2011 Jan; 16(1):24-8. PubMed ID: 21206441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E
    J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.
    Cáceres F; Vanotti S; Rao S;
    J Clin Exp Neuropsychol; 2011 Dec; 33(10):1094-8. PubMed ID: 21978317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive functions in multiple sclerosis].
    Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM
    Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue-related diurnal variations of cognitive performance in multiple sclerosis and stroke patients.
    Claros-Salinas D; Bratzke D; Greitemann G; Nickisch N; Ochs L; Schröter H
    J Neurol Sci; 2010 Aug; 295(1-2):75-81. PubMed ID: 20510427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.
    Penner IK; Raselli C; Stöcklin M; Opwis K; Kappos L; Calabrese P
    Mult Scler; 2009 Dec; 15(12):1509-17. PubMed ID: 19995840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive dysfunction as a hidden multiple sclerosis related symptom relevant for an expert appraisal].
    Kraus J; Lohmann H; Evers S
    Fortschr Neurol Psychiatr; 2009 Jan; 77(1):38-43. PubMed ID: 19101878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign multiple sclerosis: a new definition of this entity is needed.
    Correale J; Peirano I; Romano L
    Mult Scler; 2012 Feb; 18(2):210-8. PubMed ID: 21865415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.